Global Nanoparticles Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nanoparticles Market Research Report 2024
A nanoparticle is an individual molecule that behaves as a whole unit in terms of its transport and properties. The particle size of nanoparticles is 1 to 100 nanometers. The nanoparticles are further classified according to diameter as ultrafine particles (between 1 and 100 nanometers in size), fine particles (between 100 and 2,500 nanometers), and coarse particles (2,500 and 10,000 nanometers).
According to MRAResearch’s new survey, global Nanoparticles market is projected to reach US$ 149050 million in 2033, increasing from US$ 90960 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanoparticles market research.
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nanoparticles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology
Segment by Type
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nanoparticles report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Nanoparticles market is projected to reach US$ 149050 million in 2033, increasing from US$ 90960 million in 2022, with the CAGR of 7.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nanoparticles market research.
Due to a wide variety of potential applications in biomedical, optical, and electronic fields the nanoparticle research is currently an area of intense scientific research. There are various applications of nanoparticles in drug delivery. Nanotechnology is widely used in the health care industry in applications such as neurology, anti-infective, cardiovascular disorders, and others. The expanding medical diagnostics industry, increasing growth in advance healthcare technology and high advantages in medicinal imaging applications are some of the key drivers that are fuelling the growth of global nanoparticles market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nanoparticles market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Novartis
Gilead Sciences
Johnson & Johnson
Amgen
Sigma-Tau Pharmaceuticals
Abraxis Biosciences
Nano Interface Technology
Segment by Type
Liposomes
Polymer-Conjugated Drugs
Polymeric Nanoparticles
Dendrimers
Inorganic Nanoparticles
Others
Segment by Application
Hospitals
Ambulatory Surgery Centers
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Nanoparticles report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source